Mind The Gap: Does Your CTMS Support Adaptive Clinical Trials?

In their ongoing search for drugs, vaccines and medical treatments that can save or enhance patients’ lives, medical research and healthcare organizations increasingly rely on clinical trial management systems (CTMS) to manage their clinical trials. As a result, market research shows that the value of the global CTMS market is expected to grow from $44 million in 2013 to more than $1.8 billion in 2019.

Currently, organizations can choose from more than 70 Clinical Trial Management Systems, all of which provide core functionality for site management, financial tracking, and basic trial scheduling. Where many clinical trial management systems fall short, however, is in providing the extended functionalities required for data collection and electronic case-report forms, trial supply management, monitoring tools, advanced scheduling, and integration with ancillary systems.